KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 35 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,632,928 | $14,902,000 | 6.60% |
| DAFNA Capital Management LLC | 79,834 | $452,000 | 0.66% |
| Lehman Brothers Holdings Inc. | 1,067,059 | $6,040,000 | 0.28% |
| WALL STREET ASSOCIATES | 413,000 | $2,338,000 | 0.24% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 265,112 | $1,501,000 | 0.20% |
| PRIMECAP MANAGEMENT CO/CA/ | 3,681,675 | $20,838,000 | 0.03% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 93,561 | $530,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 69,379 | $393,000,000 | 0.01% |
| PRINCIPAL FINANCIAL GROUP INC | 300,000 | $1,698,000 | 0.00% |
| FMR LLC | 2,307,829 | $12,223,000 | 0.00% |